A

Akumin

Outsourced radiology and oncology services

Radiation Therapist

Full-TimeUpdated on 10/23/2026
No salary listed
Mid
Associate's
Charleston, WV, USA
In Person
Medical, Clinical & Veterinary

About the job

Requirements
  • An associate’s degree or college/technical certification in an ARRT-accredited Radiation Therapy Program is required.
  • ARRT (T) certification is required.
  • State licensure is required where applicable.
  • CPR certification is required.
  • COVID-19 vaccination may be a condition of employment.
  • Candidates accepting an offer must successfully complete a pre-employment background check and drug screen.
  • The employee must be fully mobile and able to participate in vigorous activity, including walking in and out of the treatment room throughout the day, lifting potentially heavy cerrobend blocks and electron cones, and transferring and moving patients as necessary.
  • More than 50% of the time, the employee must sit, stand, and walk; perform repetitive movement of the hands, arms, and legs; and see, speak, and hear to communicate with patients.
  • Less than 50% of the time, the employee must stoop, kneel, or crawl; climb and balance; and carry and lift, including moving non-ambulatory patients from a sitting or lying position for transfer or examination.
  • The employee may be exposed to radioactive isotopes, ionizing radiation, blood and body fluids, and infectious disease in a standard office environment.
Responsibilities
  • Deliver radiation treatment according to written prescriptions and treatment plans, following departmental procedures to ensure patient safety. Treatment delivery includes identifying the correct patient, escorting the patient to the treatment room, assisting the patient onto the treatment table, positioning the patient, delivering radiation from the control room, and assisting the patient in exiting the room.
  • Provide a consistent environment of care, concern, and support for patients, visitors, medical staff, and coworkers.
  • Ensure treatment delivery quality through complete and accurate documentation of treatment records; recognize deviations from prescribed treatment delivery and report them to the Chief Therapist and/or Physicist.
  • Explain treatment-related procedures to patients and families, refer medical questions to appropriate personnel, respond to patient concerns, observe and communicate expected and unexpected treatment reactions to appropriate staff, reinforce patient education and side-effect management information, and report non-compliance to medical and nursing staff.
  • Independently perform patient simulations at physicians’ requests; collect and document simulation data; accurately enter treatment-related data into the electronic medical record; and make appropriate patient-centric recommendations to the physician.
  • Assist with treatment-related procedures, including transporting patients, reviewing charts, and ordering supplies.
  • Recognize standard imaging and image-guided radiation therapy and make necessary adjustments to ensure high-quality treatment.
  • Perform and document daily and weekly quality assurance checklists; notify appropriate clinical team members and document findings outside the normal operating range.
  • Participate in programs to measure and improve quality of care within the department, and use critical thinking to troubleshoot and often resolve common quality issues.
  • Capture and verify patient treatment charges.

About the company

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups across the United States through a network of fixed-site outpatient imaging centers and outpatient radiology and oncology services. It operates imaging centers and partners with healthcare facilities to offer diagnostic imaging, interpretation, and related outpatient services at scale across 47 states. Its nationwide focus on outsourced radiology and oncology allows hospitals to access imaging and cancer-care resources without maintaining all services in-house. The company aims to be a trusted partner for healthcare providers by delivering reliable, scalable imaging and cancer-care services that improve patient access to diagnostics and treatment.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Get referred to Akumin

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 Plantation renovation with United Imaging showcases premium imaging demand.
  • June 2026 New Berlin facility expands capacity for relocatable clinics across 48 states.
  • Serving about 1,000 hospitals and health systems anchors recurring referral and contract volume.

What critics are saying

  • October 2023 ransomware triggered operations shutdown and 2025 breach settlement costs.
  • Akumin’s 2024 bankruptcy and delisting destroyed public-market optionality and stakeholder trust.
  • United Imaging alliance and AXIS rollout require flawless execution; delays weaken Stonepeak-backed turnaround.

What makes Akumin unique

  • Stonepeak owns Akumin after February 2024 deleveraging, giving financing stability.
  • Akumin AXIS clinics launch fully relocatable MRI, PET, and LINAC-capable outpatient sites.
  • June 2026 MHI joint venture with CGS Premier industrializes clinic production in Wisconsin.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours

Growth & Insights and Company News

6 month growth

23%

1 year growth

27%

2 year growth

27%
Business Wire
Jun 23rd, 2026
Akumin and CGS Premier launch joint venture to scale relocatable imaging and oncology clinics

Akumin, a provider of diagnostic imaging and oncology solutions, has partnered with Wisconsin-based manufacturer CGS Premier to form Mobile Healthcare Innovations (MHI), a joint venture focused on producing Akumin AXIS relocatable clinics. The partners have opened an 85,400-square-foot facility in New Berlin, Wisconsin, designed for high-volume production. Akumin AXIS units are self-contained imaging and oncology clinics with pre-installed MRI, PET or LINAC technology. The venture aims to address growing demand for imaging and oncology services across the United States. Akumin operates one of the nation's largest networks of fixed-site radiology centres and mobile solutions, partnering with over 800 hospitals and physician groups. The investment supports local job creation whilst positioning Akumin for continued expansion.

Radiology Business
Jan 5th, 2026
Akumin secures $154M investment and restructures debt to extend repayment timeline to 2031

Akumin Inc. has secured $154 million in new capital from Stonepeak, an alternative investment firm, to support long-term growth of its imaging and radiation oncology services. The company is also restructuring its debt with noteholders representing over 95% of its outstanding senior secured notes. Under the agreement, Akumin's existing debt will be exchanged for new senior secured notes due in 2031, carrying a 9.75% interest rate that can drop to 8.75% if certain credit targets are met. The company's revolving credit facility, with roughly $119 million outstanding, will convert into preferred equity or move to a lower-priority position. The restructuring follows Akumin's recent launch of new offerings at the Radiological Society of North America meeting, including its Axis Drop Trailer and relocatable MRI suites.

CanTech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal